AIFunding
FUNDING GAP:
Reid Hoffman Leaves Microsoft Board As Manus Pulls AI Drug Discovery Into Focus
Reid Hoffman is leaving Microsoft’s board after nearly a decade to focus on Manus, the AI-powered drug discovery startup he co-founded.
Manus has raised over $50 million across two seed rounds, with General Catalyst among its backers and Dr. Siddhartha Mukherjee serving as CEO.
The next signal is whether Manus can turn Hoffman’s founder focus into source-backed drug discovery milestones beyond early funding and AI positioning.
